Pulmatrix's Reverse Merger Round

Pulmatrix raised a round of funding on March 17, 2015. Investors include Ruthigen.

Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily…

Articles about Pulmatrix's Reverse Merger Round: